164 related articles for article (PubMed ID: 33912301)
1. Reduced cervical cancer screening in Zimbabwe as an indirect impact of the COVID-19 pandemic: implications for prevention.
Murewanhema G
Pan Afr Med J; 2021; 38():131. PubMed ID: 33912301
[TBL] [Abstract][Full Text] [Related]
2. The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations.
Murewanhema G
Pan Afr Med J; 2021; 39():149. PubMed ID: 34527165
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
Poljak M; Cuschieri K; Waheed DE; Baay M; Vorsters A
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):21-26. PubMed ID: 33765753
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
5. Utilization and outcomes of cervical cancer screening services in Harare City, 2012-2016: a secondary data analysis.
Gabaza C; Chonzi P; Chadambuka A; Shambira G; Juru TP; Gombe NT; Nsubuga P; Tshimanga M
BMC Health Serv Res; 2019 Jul; 19(1):454. PubMed ID: 31277655
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 pandemic causes cervical cancer screening crisis.
Gourd E
Lancet Oncol; 2021 Aug; 22(8):1060. PubMed ID: 34175038
[No Abstract] [Full Text] [Related]
7. Restoring and maintaining robust maternity services in the COVID-19 era: a public health dilemma in Zimbabwe.
Murewanhema G; Nyakanda MI; Madziyire MG
Pan Afr Med J; 2020; 37(Suppl 1):32. PubMed ID: 33456656
[TBL] [Abstract][Full Text] [Related]
8. Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
Castanon A; Rebolj M; Burger EA; de Kok IMCM; Smith MA; Hanley SJB; Carozzi FM; Peacock S; O'Mahony JF
Lancet Public Health; 2021 Jul; 6(7):e522-e527. PubMed ID: 33939965
[TBL] [Abstract][Full Text] [Related]
9. Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
Sormani J; Datchoua AM; Petignat P; Kenfack B; Schmidt NC
Int J Gynecol Cancer; 2021 Sep; 31(9):1297-1298. PubMed ID: 33712454
[No Abstract] [Full Text] [Related]
10. Experiences of cervical cancer screening in HIV-positive women in Zimbabwe.
Mpata PC; Nkosi ZZ
Curationis; 2021 Nov; 44(1):e1-e7. PubMed ID: 34797107
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
Duarte MBO; Argenton JLP; Carvalheira JBC
JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
[TBL] [Abstract][Full Text] [Related]
12. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia.
Feletto E; Grogan P; Nickson C; Smith M; Canfell K
Public Health Res Pract; 2020 Dec; 30(4):. PubMed ID: 33294902
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening: Safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe.
Fallala MS; Mash R
Afr J Prim Health Care Fam Med; 2015 May; 7(1):. PubMed ID: 26245601
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cervical cancer screening programme in the Harare City Health Department, Zimbabwe.
Moyo IM; Koni NP; Makunike B; Hipshman J; Makaure HK; Gumbo N
Cent Afr J Med; 1997 Aug; 43(8):223-5. PubMed ID: 9431759
[TBL] [Abstract][Full Text] [Related]
15. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
16. Women's knowledge, attitudes and practices (KAP) relating to breast and cervical cancers in rural Zimbabwe: a cross sectional study in Mudzi District, Mashonaland East Province.
Makurirofa L; Mangwiro P; James V; Milanzi A; Mavu J; Nyamuranga M; Kamtauni S
BMC Public Health; 2019 Jan; 19(1):109. PubMed ID: 30678659
[TBL] [Abstract][Full Text] [Related]
17. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
18. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 disruption to cervical cancer screening in England.
Castanon A; Rebolj M; Pesola F; Pearmain P; Stubbs R
J Med Screen; 2022 Sep; 29(3):203-208. PubMed ID: 35369792
[TBL] [Abstract][Full Text] [Related]
20. Gaps and opportunities for cervical cancer prevention, diagnosis, treatment and care: evidence from midterm review of the Zimbabwe cervical Cancer prevention and control strategy (2016-2020).
Tapera O; Nyakabau AM; Simango N; Guzha BT; Jombo-Nyakuwa S; Takawira E; Mapanga A; Makosa D; Madzima B
BMC Public Health; 2021 Jul; 21(1):1478. PubMed ID: 34320957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]